
Pharmaceutical brand names are the result of a highly regulated, rigorous, and often poetic design process. Because the FDA mandates that names avoid misleading medical claims and look-alike or sound-alike confusion to prevent fatal medication errors, naming experts must navigate a crowded field of only 26 letters. Specialists like Scott Piergrossi of the Brand Institute and veteran namer Arlene Taylor utilize strategies such as creating distinct visual silhouettes with ascending and descending letters and prioritizing phonetic musicality. Names like Viagra and Toujeo emerge from complex narratives, blending scientific mechanisms with emotional resonance to ensure marketability and memorability. As the number of new drug approvals increases, the challenge of finding unique, trademarkable, and safe names has transformed pharmaceutical branding into a sophisticated blend of linguistic artistry and strict regulatory compliance.
Sign in to continue reading, translating and more.
Continue